X

VistaGen Therapeutics, Inc (VTGN) VistaGen Therapeutics to Report Fiscal Year 2022 Second Quarter Financial Results and Recent Developments on November 10, 2021

VistaGen Therapeutics, Inc (NASDAQ: VTGN) Q2 2022 Earnings Conference

Newsdesk: